ID: ALA2146585

Max Phase: Preclinical

Molecular Formula: C19H16N2O2

Molecular Weight: 304.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(-c2cc(-c3cc4ccccc4n3C)on2)c1

Standard InChI:  InChI=1S/C19H16N2O2/c1-21-17-9-4-3-6-14(17)11-18(21)19-12-16(20-23-19)13-7-5-8-15(10-13)22-2/h3-12H,1-2H3

Standard InChI Key:  VKMWYAOENRHKAD-UHFFFAOYSA-N

Associated Targets(Human)

Calu-3 339 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.35Molecular Weight (Monoisotopic): 304.1212AlogP: 4.51#Rotatable Bonds: 3
Polar Surface Area: 40.19Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.15CX LogP: 4.02CX LogD: 4.02
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.56Np Likeness Score: -1.13

References

1. Md Tohid SF, Ziedan NI, Stefanelli F, Fogli S, Westwell AD..  (2012)  Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.,  56  [PMID:22955095] [10.1016/j.ejmech.2012.08.009]

Source